Healthcare & Life Sciences

In one of America's priciest cities, a local credit union's toy drive points to a larger innovation: the fusion of finance and community development.

Fivetran's new Gartner status reveals a deeper industry shift: the race to build the unified data plumbing that will determine if we can trust AI.

A $2.4B deal for Alphawave IP and a revealing investor filing pull back the curtain on the high-stakes race to build the infrastructure for an AI world.

Recent product recalls reveal deep flaws in our safety systems. What can this teach us about regulating the complex world of medical AI before it's too late?

Fidelity Building Services' latest acquisition of St. Johns Air highlights a major consolidation trend impacting everything from data centers to hospitals.

Subsense just raised $27M for a BCI delivered via nasal spray. It could democratize neurotech, but what's the cost to our identity and safety?

NextNRG's latest healthcare microgrid deal reveals a high-stakes strategy: turning regulatory pressure into long-term, AI-driven recurring revenue.

A new pediatric network is betting it can fix fragmented care with integrated tech and a focus on clinicians. Its latest target: Atlanta's crowded market.

A Florida health center's new pharmacy is more than a convenience. It's a look into a powerful model blending tech and finance to create sustainable care.

A new report reveals the risks of burnout and the strategic value of workforce well-being. For luxury brands and investors, human capital is the new frontier.

Inotiv partners with AI firm VUGENE, but this is no simple tech deal. It's a high-stakes move to compete in a market dominated by AI-powered giants.

Backed by $18M in seed funding, 25-year-old founder Harry Gestetner is launching an AI-powered smart mattress cover to transform longevity through sleep.

Xtant Medical's new nanOss Strata bone graft isn't just an update; it's a strategic move to disrupt the orthobiologics market. Here's why it matters.

Astellas Pharma's new deal with venture studio Autobahn Labs isn't just a partnership; it's a strategic overhaul of the R&D pipeline. Here's why.

A third-generation family takeover, backed by Canada's BDC, positions a 70-year-old firm to accelerate innovation in the competitive medical imaging market.

As elder isolation becomes a public health emergency in Quebec, one non-profit's strategy of sustained human connection offers a powerful brand lesson.

As agencies retool for a complex market, Bastion's appointment of a cultural PR expert highlights a critical shift for pharma and beyond.

Planisware targets APAC growth with a new Australian office and two data centers, betting on data sovereignty and AI to win in a competitive market.

South Korean tobacco giant KT&G just earned a flawless 'AAA' ESG rating, a first for its industry. What does this mean for investors and sustainability?

Darling Ingredients' new venture with Tessenderlo isn't just a merger; it's a strategic move to dominate the booming collagen and nutrition market.